236 related articles for article (PubMed ID: 17906021)
1. Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.
Northen AT; Norman GS; Anderson K; Moseley L; Divito M; Cotroneo M; Swain M; Bousleiman S; Johnson F; Dorman K; Milluzzi C; Tillinghast JA; Kerr M; Mallett G; Thom E; Pagliaro S; Anderson GD;
Obstet Gynecol; 2007 Oct; 110(4):865-72. PubMed ID: 17906021
[TBL] [Abstract][Full Text] [Related]
2. Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.
Mainiero AD; Rouse DJ; Lopes V; Hughes BL
Obstet Gynecol; 2015 Jul; 126(1):103-8. PubMed ID: 26241262
[TBL] [Abstract][Full Text] [Related]
3. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
Mulder EJ; Versteegh EM; Bloemenkamp KW; Lim AC; Mol BW; Bekedam DJ; Kwee A; Bruinse HW; Christiaens GC
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):329-34. PubMed ID: 23592400
[TBL] [Abstract][Full Text] [Related]
4. 17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Merlob P; Stahl B; Klinger G
Reprod Toxicol; 2012 Jan; 33(1):15-9. PubMed ID: 22120850
[TBL] [Abstract][Full Text] [Related]
5. Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy.
Waters TP; Schultz BAH; Mercer BM; Catalano PM
Obstet Gynecol; 2009 Jul; 114(1):45-49. PubMed ID: 19546757
[TBL] [Abstract][Full Text] [Related]
6. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.
Resseguie LJ; Hick JF; Bruen JA; Noller KL; O'Fallon WM; Kurland LT
Fertil Steril; 1985 Apr; 43(4):514-9. PubMed ID: 3987922
[TBL] [Abstract][Full Text] [Related]
7. Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate.
Bailit JL; Votruba ME
Am J Obstet Gynecol; 2007 Mar; 196(3):219.e1-7. PubMed ID: 17346527
[TBL] [Abstract][Full Text] [Related]
8. Absence of harmful effects of magnetic resonance exposure at 1.5 T in utero during the third trimester of pregnancy: a follow-up study.
Kok RD; de Vries MM; Heerschap A; van den Berg PP
Magn Reson Imaging; 2004 Jul; 22(6):851-4. PubMed ID: 15234454
[TBL] [Abstract][Full Text] [Related]
9. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
Caritis SN; Rouse DJ; Peaceman AM; Sciscione A; Momirova V; Spong CY; Iams JD; Wapner RJ; Varner M; Carpenter M; Lo J; Thorp J; Mercer BM; Sorokin Y; Harper M; Ramin S; Anderson G;
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):285-92. PubMed ID: 19155896
[TBL] [Abstract][Full Text] [Related]
10. The use of progestational agents for preterm birth: lessons from a mouse model.
Elovitz MA; Mrinalini C
Am J Obstet Gynecol; 2006 Oct; 195(4):1004-10. PubMed ID: 17000233
[TBL] [Abstract][Full Text] [Related]
11. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
Hartikainen-Sorri AL; Kauppila A; Tuimala R
Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron supplementation during pregnancy on the behaviour of children at early school age: long-term follow-up of a randomised controlled trial.
Parsons AG; Zhou SJ; Spurrier NJ; Makrides M
Br J Nutr; 2008 May; 99(5):1133-9. PubMed ID: 17967217
[TBL] [Abstract][Full Text] [Related]
13. In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.
Murphy CC; Cirillo PM; Krigbaum NY; Cohn BA
Am J Obstet Gynecol; 2022 Jan; 226(1):132.e1-132.e14. PubMed ID: 34767803
[TBL] [Abstract][Full Text] [Related]
14. Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse.
Carbone JP; Brent RL
Am J Obstet Gynecol; 1993 Nov; 169(5):1292-8. PubMed ID: 8238197
[TBL] [Abstract][Full Text] [Related]
15. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.
Gyamfi C; Horton AL; Momirova V; Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Meis PJ; Spong CY; Dombrowski M; Sibai B; Varner MW; Iams JD; Mercer BM; Carpenter MW; Lo J; Ramin SM; O'Sullivan MJ; Miodovnik M; Conway D;
Am J Obstet Gynecol; 2009 Oct; 201(4):392.e1-5. PubMed ID: 19716543
[TBL] [Abstract][Full Text] [Related]
16. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
Peltoniemi OM; Kari MA; Lano A; Yliherva A; Puosi R; Lehtonen L; Tammela O; Hallman M;
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F402-6. PubMed ID: 19531521
[TBL] [Abstract][Full Text] [Related]
17. The effects of in utero diagnostic X-irradiation on the development of preschool-age children.
Ornoy A; Patlas N; Schwartz L
Isr J Med Sci; 1996 Feb; 32(2):112-5. PubMed ID: 8631646
[TBL] [Abstract][Full Text] [Related]
18. Impairment of male reproduction in adult rats exposed to hydroxyprogesterone caproate in utero.
Pushpalatha T; Ramachandra Reddy P; Sreenivasula Reddy P
Naturwissenschaften; 2004 May; 91(5):242-4. PubMed ID: 15146273
[TBL] [Abstract][Full Text] [Related]
19. Prenatal ultrasound exposure and children's school performance at age 15-16: follow-up of a randomized controlled trial.
Stålberg K; Axelsson O; Haglund B; Hultman CM; Lambe M; Kieler H
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):297-303. PubMed ID: 19705400
[TBL] [Abstract][Full Text] [Related]
20. Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice.
Rebarber A; Fox NS; Klauser CK; Istwan NB; Rhea DJ; Stanziano GJ; Saltzman DH
J Matern Fetal Neonatal Med; 2010 Oct; 23(10):1139-42. PubMed ID: 20170407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
